Selected Publications

Wachsmuth Rachel C, Harland Mark, Newton Bishop Julia A. The atypical mole syndrome and predisposition to melanoma. New Eng. J. Med. 1998; 339: 348-349.

Harland M, Holland EA, Ghiorzo P, Mantelli M, Bianchi-Scarra G, Goldstein AM, Tucker MA, Ponder BAJ, Mann G, Bishop DT, Newton Bishop JA. Mutation screening of the CDKN2A promotor in melanoma families. Genes, Chromosomes and Cancer. 2000; 28: 45-57.

Randerson-Moor JA, Harland M, Williams S, Cathbert-Heavens D, Sheridan E, Aveyard J, Sibley K, Whiatker L, Knowles M, Newton Bishop JA, Bishop DT. A germline deletion of p14ARF but not CDKN2A in a melanoma-neural system tumour syndrome family. Hum Mol Genet. 2001: 10: 55-62.

Harland M, Mistry S, Bishop DT and Newton Bishop JA. A deep intronic mutation in CDKN2A is associated with disease in a subset of melanoma pedigrees. Hum. Molec. Genet. 2001; 10: 2679-2686.

Bertram CG, Gaut RM, Barrett JH, Pinney E, Whitaker L, Turner F, Bataille V, Isabel dos Santos Silva, Swerdlow AJ, Bishop DT, Newton Bishop JA. An assessment of the CDKN2A variant ala148thr as a nevus / melanoma susceptibility allele. Journal of Investigative Dermatology. 2002; 119: 961-965.